Pharmacology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
<br> | <br> | ||
== Socio-pharmacology == | == Socio-pharmacology == | ||
| Line 27: | Line 25: | ||
[http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0030240 Do Antidepressants Cure or Create Abnormal Brain States?] | [http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.0030240 Do Antidepressants Cure or Create Abnormal Brain States?] | ||
Joanna Moncrieff and David Cohen | Joanna Moncrieff and David Cohen | ||
<br>Neuro-pharmacology | <br>Neuro-pharmacology | ||
| Line 43: | Line 41: | ||
<br> | <br> | ||
Anthro-pharmacology | == Anthro-pharmacology == | ||
[[The evolutionary origins and significance of drug addiction]] | [[The evolutionary origins and significance of drug addiction]] | ||
Tammy Saah<br> | Tammy Saah<br> | ||
[http://kcl.academia.edu/RichardSullivan/Papers/258342/Why_do_we_love_medicines_so_much Why Do We Love Medicines So Much?] | |||
Richard Sullivan, Isabel Behncke and Arnie Purushotham | |||
== Juridico-pharmacology<br> == | == Juridico-pharmacology<br> == | ||
Revision as of 14:05, 11 July 2011
Introduction (coming soon)
Drugs 'R Us
Dave Boothroyd
Socio-pharmacology
Epidemiology Meets Cultural Studies: Studying and Understanding Youth Cultures, Clubs and Drugs
Geoffrey Hunt, Molly Moloney, and Kristin Evans
Misuse of "study drugs:" prevalence, consequences, and implications for policy
Steve Sussman, Mary A Pentz, Donna Spruijt-Metz and Toby Miller
Coming to terms with the nonmedical use of prescription medications
Carol J Boyd and Sean E McCabe
Psycho-pharmacology
Psychopharmacology and the Goverment of the Self
David Healy
Do Antidepressants Cure or Create Abnormal Brain States?
Joanna Moncrieff and David Cohen
Neuro-pharmacology
The Dark Side of Ecstasy: Neuropsychiatric Symptoms After Exposure to 3,4-Methylenedioxymetamphetamine
Sunniva Nyberg Karlsen, Olav Spigset, LARS Slørdal
Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs
John H. Halpern, Andrea R. Sherwood, James I. Hudson, Staci Gruber, David Kozin, Harrison G. Pope Jr
Effectiveness of antidepressants: an evidence myth constructed
from a thousand randomized trials?
John PA Ioannidis
Should We Treat Depression with drugs or
psychological interventions? A Reply to Ioannidis
John M Davis, William J Giakas, Jie Qu, Pavan Prasad and Stefan Leucht
Ethno-pharmacology
Naming a Phantom - the Quest to Find the Identity of the Ulluchu, an Unidentified Cerimonial Plant of the Moche Culture in Northern Peru
Rainer W Bussmann and Douglas Sharon
Absinthism: A Fictitious 19th. Centrury Syndrome with Present Impact
Stephan A Padosch, Dirk W Lachenmeier and Lars U Kröner
The “Vine of the Soul” vs. The Controlled Substances Act: Implications of the Hoasca Case
Ronald K. Bullis
Anthro-pharmacology
The evolutionary origins and significance of drug addiction
Tammy Saah
Why Do We Love Medicines So Much?
Richard Sullivan, Isabel Behncke and Arnie Purushotham
Juridico-pharmacology
Our Right to Drugs
An interview with Thomas Szasz
Global Commission on Drugs Report (2011)
Drug Policy – Lessons Learnt, and Options for the Future
Mike Trace
The UK’s Treatment War on Drugs: A Lesson in Unintended Consequences and Perverse Outcomes
Kathy Gyngell
Cultural psycho-pharmacology
Timothy Leary, Cooper Union Addess, 1964
Drugs in Theory
Dave Boothroyd
Machinic Assemblages: Deleuze, Guattari and an Ethico-Aesthetics of Drug Use
Peta Malins